Onxeo S.A.: Onxeo: Publication of the 2022 Annual Financial Report

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), hereafter "Onxeo" or the "Company", a clinical-stage biotechnology company specializing in the development of innovative drugs targeting

Related Keywords

Paris ,France General ,France ,Onxeo Sa Euronext ,Nicolas Fossiez ,Arthur Rouill , ,Regulatory News ,Euronext Growth Paris ,Onxeo ,Publication ,022 ,Nnual ,Financial ,Report ,